Cost-Effectiveness Analysis Between Sacral Neuromodulation and OnabotulinumtoxinA for the Treatment of Refractory Overactive Bladder in Women: A Systematic Review.

Gerjevic, Kristen A; Ahmad, Sophia; Strohbehn, Kris; Riblet, Natalie

Gerjevic, Kristen A; Ahmad, Sophia; Strohbehn, Kris; Riblet, Natalie.

Afiliação

Gerjevic KA; From the Department of Obstetrics and Gynecology, Geisel School of Medicine at Dartmouth, Lebanon, NH.
Strohbehn K; From the Department of Obstetrics and Gynecology, Geisel School of Medicine at Dartmouth, Lebanon, NH.
Riblet N; The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH.

Female Pelvic Med Reconstr Surg ; 27(8): 481-487, 2021 08 01.

Article em En | MEDLINE | ID: mdl-34074937

Assuntos

Toxinas Botulínicas Tipo A/economia; Terapia por Estimulação Elétrica/economia; Bexiga Urinária Hiperativa/terapia; Toxinas Botulínicas Tipo A/uso terapêutico; Análise Custo-Benefício; Feminino; Humanos; Bexiga Urinária Hiperativa/economia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google